UK cardiology market is estimated to grow significantly at a CAGR of around 6.4% during the forecast period. UK has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease that further contributing to the growth of the market. According to one of the reports published by the British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. The above data reflects the mortalities recorded in England, Wales, Scotland and Northern Ireland. A total of 56,493 mortalities were recorded in England followed by 7,182 in Scotland. Similarly, Wales and Northern Ireland reported 4,082 and 1,825 deaths respectively. These numbers of mortalities and incidence of heart related diseases increase the demand for cardiology devices, drugs and surgeries that further propels the market growth.
To Request a Sample of our Report on UK Cardiology Market: https://www.omrglobal.com/request-sample/uk-cardiology-market
The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.
(Get 15% Discount on Buying this Report)
A full Report of UK Cardiology Market is Available at: https://www.omrglobal.com/industry-reports/uk-cardiology-market
UK Cardiology Market Segmentation
By Device Type
· Angioplasty
· Cardiovascular stents
· Cardiovascular catheters
· Cardiac rhythm management
· Cardiovascular assistive devices
By Drug Type
· Antithrombotic drugs
· Antidyslipidemic drugs
· Antihypertensive drugs
· Anti-stroke drugs
By Mechanism
· Beta blockers
· Beta agonists
· Alpha blockers
· Alpha agonists
· Sodium channel blockers
· Calcium channel blockers
· Vasodilators
· Renin inhibitors
· Angiotensin receptor blockers
· Diuretics
· Thrombolytics
By Surgeries Type
· Coronary artery bypass grafting
· Transmyocardial laser revascularization
· Heart valve repair
· Arrhythmia treatment
· Aneurysm repair
· Heart transplant
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
